Coagulation Rapid Test

The LumiraDx INR Test measures prothrombin time, which is reported as an International Normalized Ratio (INR) from a single, direct fingerstick blood sample, all in less than 90 seconds*. The Test is employed to monitor patients who are undergoing oral anticoagulation therapy with Vitamin-K Antagonist (VKA) drugs. The Test provides immediate results at the point of care when used in conjunction with the LumiraDx Instrument.input:
output:Benefits of testinginput:
output:The preferred test for monitoring patients on vitamin K antagonist (VKA) therapy is INR. Laboratory testing is the current standard method for monitoring INR. Nevertheless, the LumiraDx INR Test is administered at the point of care, which offers numerous advantages over laboratory testing.input:
output:
Convenience enhanced through on-site testing at the patient’s locationinput:
output:Faster turnaround times than laboratory testing—results in less than 90 seconds*input:
output:Improved clinical outcomes are the result of faster diagnosis and treatment management.input:
output:Reduced referral volume – alleviating the burden on secondary careinput:
output:Precise and accurate – CVs <5% and correlation with the Instrumentation Laboratory ACL Elite laboratory reference methodinput:
output:Storage of Test Strips at room temperatureinput:
output:Test the workflow.input:
output:In order to guarantee that the Instrument and Test Strips are functioning properly during each test run, they are integrated with numerous quality control checks.input:
output:The workflow process consists of a single fingerstick to the Test Strip and direct application, as well as step-by-step guidance from the Instrument to report a patient result.input:
output:Performance assessmentinput:
output:The LumiraDx INR Test demonstrated a strong correlation with the Instrumentation Laboratory ACL Elite laboratory reference method in the OPTIMAL clinical trial.